Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells

Cellular and Molecular Life Sciences

Volumn 71, Issue 10, 2014, Pages 1943-1960

  Peters, Christian ^a   Oberg, Hans Heinrich ^a   Kabelitz, Dieter ^a   Wesch, Daniela ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

CD86; CTLA 4; FoxP3; Helios; Immunosuppressive V 2 T cells; Phosphorylation; Toll like receptor 2 ligands

Indexed keywords

CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HELIOS; UNCLASSIFIED DRUG;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL CONTACT; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME PHOSPHORYLATION; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANTIGENS, CD86; CELLS, CULTURED; COCULTURE TECHNIQUES; CTLA-4 ANTIGEN; DIGLYCERIDES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSION; LIPOPEPTIDES; MITOGEN-ACTIVATED PROTEIN KINASES; OLIGOPEPTIDES; PHENOTYPE; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 2;

EID: 84900300490     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1467-1     Document Type: Article

References (69)

1. Himoudi N, Morgenstern DA, Yan M, Vernay B, Saraiva L, Wu Y, Cohen CJ, Gustafsson K, Anderson J (2012) Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells. J Immunol 188:1708-1716
2. Meuter S, Eberl M, Moser B (2010) Prolonged antigen survival and cytosolic export in cross-presenting human γδ T cells. Proc Natl Acad Sci USA 107:8730-8735
3. Poupot M, Pont F, Fournie JJ (2005) Profiling blood lymphocyte interactions with cancer cells uncovers the innate reactivity of human γδ T cells to anaplastic large cell lymphoma. J Immunol 174:1717-1722
4. Wrobel P, Shojaei H, Schittek B, Gieseler F, Wollenberg B, Kalthoff H, Kabelitz D, Wesch D (2007) Lysis of a broad range of epithelial tumour cells by human γδ T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Scand J Immunol 66:320-328
5. Wu Y, Wu W, Wong WM, Ward E, Thrasher AJ, Goldblatt D, Osman M, Digard P, Canaday DH, Gustafsson K (2009) Human γδ T cells: a lymphoid lineage cell capable of professional phagocytosis. J Immunol 183:5622-5629
6. Nedellec S, Sabourin C, Bonneville M, Scotet E (2010) NKG2D costimulates human Vγ9 Vδ2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals. J Immunol 185:55-63
7. Ribot JC, Debarros A, Silva-Santos B (2011) Searching for "signal 2": costimulation requirements of γδ T cells. Cell Mol Life Sci 68:2345-2355
8. Wesch D, Beetz S, Oberg HH, Marget M, Krengel K, Kabelitz D (2006) Direct costimulatory effect of TLR3 ligand poly(I:C) on human γδ T lymphocytes. J Immunol 176:1348-1354
9. Wesch D, Peters C, Oberg HH, Pietschmann K, Kabelitz D (2011) Modulation of γδ T cell responses by TLR ligands. Cell Mol Life Sci 68:2357-2370
10. Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, De LG (2003) Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 197:163-168
11. Pietschmann K, Beetz S, Welte S, Martens I, Gruen J, Oberg HH, Wesch D, Kabelitz D (2009) Toll-like receptor expression and function in subsets of human γδ T lymphocytes. Scand J Immunol 70:245-255
12. Pechhold K, Wesch D, Schondelmaier S, Kabelitz D (1994) Primary activation of Vγ9-expressing γδ T cells by Mycobacterium tuberculosis. Requirement for Th1-type CD4 T cell help and inhibition by IL-10. J Immunol 152:4984-4992
13. Angelini DF, Borsellino G, Poupot M, Diamantini A, Poupot R, Bernardi G, Poccia F, Fournie JJ, Battistini L (2004) FcγRIII discriminates between 2 subsets of Vγ9 Vδ2 effector cells with different responses and activation pathways. Blood 104:1801-1807
14. Caccamo N, Meraviglia S, Ferlazzo V, Angelini D, Borsellino G, Poccia F, Battistini L, Dieli F, Salerno A (2005) Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vγ9 Vδ2 naive, memory and effector T cell subsets. Eur J Immunol 35:1764-1772
15. Conti L, Casetti R, Cardone M, Varano B, Martino A, Belardelli F, Poccia F, Gessani S (2005) Reciprocal activating interaction between dendritic cells and pamidronate-stimulated γδ T cells: role of CD86 and inflammatory cytokines. J Immunol 174:252-260
16. Martino A, Poccia F (2007) Gamma delta T cells and dendritic cells: close partners and biological adjuvants for new therapies. Curr Mol Med 7:658-673
17. Traxlmayr MW, Wesch D, Dohnal AM, Funovics P, Fischer MB, Kabelitz D, Felzmann T (2010) Immune suppression by γδ T-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells. J Immunother 33:40-52
18. Sakaguchi S (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531-562
19. Peterson RA (2012) Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol 40:186-204
20. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, Shevach EM (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3 + T regulatory cells. J Immunol 184:3433-3441
21. Tran DQ, Ramsey H, Shevach EM (2007) Induction of FOXP3 expression in naive human CD4+ FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110:2983-2990
22. Bettelli E, Dastrange M, Oukka M (2005) Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 102:5138-5143
23. Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hartgers FC, Elferink BG, van der Zanden L, de Vries RR, Huizinga TW, Ottenhoff TH, Toes RE (2005) Expression of FOXP3 mRNA is not confined to CD4+ CD25+ T regulatory cells in humans. Hum Immunol 66:13-20
24. Casetti R, Agrati C, Wallace M, Sacchi A, Martini F, Martino A, Rinaldi A, Malkovsky M (2009) Cutting edge: TGF-β1 and IL-15 Induce FOXP3+ γδ regulatory T cells in the presence of antigen stimulation. J Immunol 183:3574-3577
25. Clemente A, Cambra A, Munoz-Saa I, Crespi C, Pallares L, Juan A, Matamoros N, Julia MR (2010) Phenotype markers and cytokine intracellular production by CD8+ γδ T lymphocytes do not support a regulatory T profile in Behcet's disease patients and healthy controls. Immunol Lett 129:57-63
26. Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W (2009) Identification and characterization of Foxp3(+) γδ T cells in mouse and human. Immunol Lett 125:105-113
27. Kelley CM, Ikeda T, Koipally J, Avitahl N, Wu L, Georgopoulos K, Morgan BA (1998) Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol 8:508-515
28. Akimova T, Beier UH, Wang L, Levine MH, Hancock WW (2011) Helios expression is a marker of T cell activation and proliferation. PLoS ONE 6:e24226
29. Gottschalk RA, Corse E, Allison JP (2012) Expression of Helios in peripherally induced Foxp3+ regulatory T cells. J Immunol 188:976-980
30. Zabransky DJ, Nirschl CJ, Durham NM, Park BV, Ceccato CM, Bruno TC, Tam AJ, Getnet D, Drake CG (2012) Phenotypic and functional properties of Helios+ regulatory T cells. PLoS ONE 7:e34547
31. Zhang Z, Swindle CS, Bates JT, Ko R, Cotta CV, Klug CA (2007) Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice. Blood 109:2190-2197
32. Cai Q, Dierich A, Oulad-Abdelghani M, Chan S, Kastner P (2009) Helios deficiency has minimal impact on T cell development and function. J Immunol 183:2303-2311
33. Sharpe AH, Freeman GJ (2002) The B7-CD28 superfamily. Nat Rev Immunol 2:116-126
34. de la Fuente H, Cibrian D, Sanchez-Madrid F (2012) Immunoregulatory molecules are master regulators of inflammation during the immune response. FEBS Lett 586:2897-2905
35. Sharpe AH (2009) Mechanisms of costimulation. Immunol Rev 229:5-11
36. Acuto O, Michel F (2003) CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 3:939-951
37. Bour-Jordan H, Bluestone JA (2009) Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev 229:41-66
38. Freeman GJ (2008) Structures of PD-1 with its ligands: sideways and dancing cheek to cheek. Proc Natl Acad Sci USA 105:10275-10276
39. Oberg HH, Ly TT, Ussat S, Meyer T, Kabelitz D, Wesch D (2010) Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands. J Immunol 184:4733-4740
40. Oberg HH, Juricke M, Kabelitz D, Wesch D (2011) Regulation of T cell activation by TLR ligands. Eur J Cell Biol 90:582-592
41. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373-384
42. O'Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7:353-364
43. Oberg HH, Wesch D, Lenke J, Kabelitz D (2006) An optimized method for the functional analysis of human regulatory T cells. Scand J Immunol 64:353-360
44. Pechhold K, Pohl T, Kabelitz D (1994) Rapid quantification of lymphocyte subsets in heterogeneous cell populations by flow cytometry. Cytometry 16:152-159
45. Klas C, Debatin KM, Jonker RR, Krammer PH (1993) Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5:625-630
46. Kabelitz D, Peters C, Wesch D, Oberg HH (2013) Regulatory functions of γδ T cells. Int Immunopharmacol 16:382-387
47. Deetz CO, Hebbeler AM, Propp NA, Cairo C, Tikhonov I, Pauza CD (2006) γ interferon secretion by human Vγ2 Vδ2 T cells after stimulation with antibody against the T-cell receptor plus the Toll-Like receptor 2 agonist Pam3Cys. Infect Immun 74:4505-4511
48. Santos-Sierra S, Deshmukh SD, Kalnitski J, Kuenzi P, Wymann MP, Golenbock DT, Henneke P (2009) Mal connects TLR2 to PI3 Kinase activation and phagocyte polarization. EMBO J 28:2018-2027
49. Law JP, Hirschkorn DF, Owen RE, Biswas HH, Norris PJ, Lanteri MC (2009) The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+ CD25+ Foxp3+ regulatory T cells. Cytometry A 75:1040-1050
50. Fox BC, Bignone PA, Brown PJ, Banham AH (2008) Defense of the clone: antibody 259D effectively labels human FOXP3 in a variety of applications. Blood 111:3897-3899
51. Tran DQ, Shevach EM (2008) Response: anti-human FOXP3 mAb PCH101 stains activated human naive T cells nonspecifically. Blood 11:464-466
52. Pillai V, Karandikar NJ (2008) Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity. Blood 111:463-464
53. Hansmann L, Schmidl C, Kett J, Steger L, Andreesen R, Hoffmann P, Rehli M, Edinger M (2012) Dominant Th2 differentiation of human regulatory T cells upon loss of FOXP3 expression. J Immunol 188:1275-1282
54. Verhagen J, Wraith DC (2010) Comment on "expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells". J Immunol 185:7129
55. Bruniquel D, Schwartz RH (2003) Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 4:235-240
56. Kim J, Sif S, Jones B, Jackson A, Koipally J, Heller E, Winandy S, Viel A, Sawyer A, Ikeda T, Kingston R, Georgopoulos K (1999) Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10:345-355
57. Rao S, Gerondakis S, Woltring D, Shannon MF (2003) c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J Immunol 170:3724-3731
58. Sridharan R, Smale ST (2007) Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes. J Biol Chem 282:30227-30238
59. Brandes M, Willimann K, Bioley G, Levy N, Eberl M, Luo M, Tampe R, Levy F, Romero P, Moser B (2009) Cross-presenting human γδ T cells induce robust CD8+ alphabeta T cell responses. Proc Natl Acad Sci USA 106:2307-2312
60. Moser B, Brandes M (2006) γδ T cells: an alternative type of professional APC. Trends Immunol 27:112-118
61. Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM (2005) Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood 105:1574-1581
62. Carreno BM, Carter LL, Collins M (2005) Therapeutic opportunities in the B7/CD28 family of ligands and receptors. Curr Opin Pharmacol 5:424-430
63. Beetz S, Wesch D, Marischen L, Welte S, Oberg HH, Kabelitz D (2008) Innate immune functions of human γδ T cells. Immunobiology 213:173-182
64. Correia DV, d'Orey F, Cardoso BA, Lanca T, Grosso AR, Debarros A, Martins LR, Barata JT, Silva-Santos B (2009) Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human γδ T-cells. PLoS ONE 4:e5657
65. Lafont V, Liautard J, Sable-Teychene M, Sainte-Marie Y, Favero J (2001) Isopentenyl pyrophosphate, a mycobacterial non-peptidic antigen, triggers delayed and highly sustained signaling in human gamma delta T lymphocytes without inducing down-modulation of T cell antigen receptor. J Biol Chem 276:15961-15967
66. Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD (1995) Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 92:8705-8709
67. van Seventer GA, Newman W, Shimizu Y, Nutman TB, Tanaka Y, Horgan KJ, Gopal TV, Ennis E, O'Sullivan D, Grey H (1991) Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J Exp Med 174:901-913
68. Oberg HH, Wesch D, Grussel S, Rose-John S, Kabelitz D (2006) Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+. Int Immunol 18:555-563
69. Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4+ CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033-1036